AI data centers are hitting a bandwidth wall, and the companies supplying the glass to break through it are posting revenue growth that copper simply cannot match. Five optical chip names are quietly stacking…
Silicon carbide and gallium nitride are the choke points in a $trillions electrification wave, and five U.S.-listed chip makers are already collecting the toll. One just survived bankruptcy court, and another trades like a…
Analog chip inventories just hit a turning point that historically precedes a major re-rating, and five names across auto, industrial, and AI power are positioned to capture the move before the window closes.
While investors chase GPU names, a quieter group of semiconductor companies is absorbing the real capital flowing into AI data centers, and five of them are already posting triple-digit revenue growth that Wall Street…
Silicon content per handset is quietly repricing as on-device AI and RF complexity collide with the next refresh cycle, and five chip names are already splitting into winners and losers before most investors notice…
Applied Materials just blew past its own growth forecast, and the companies supplying every HBM stack and gate-all-around node are collecting the checks. Five picks-and-shovels stocks sit directly under that spending fire hose, and…
Stifel just blew past Wall Street's AMD consensus with a target that would push the chipmaker into trillion-dollar territory, and the conditions required to get there are more specific than most investors realize.
SpaceX's historic IPO turned Elon Musk into the world's first trillionaire, and now Jeff Bezos is making the biggest bet of his life on the company he has quietly funded for 26 years.
Netflix (NASDAQ:NFLX | NFLX Price Prediction) heads into its July 16 earnings release with one of the cleanest setups in the market for a retirement portfolio, and the math is compelling. The stock is…
The 10-year Treasury yield sits at 4.49%, in the 93rd percentile of its 12-month range. That is the number every dividend investor should keep taped to their monitor this July, because it is the…
Taiwan Semiconductor Manufacturing (NYSE:TSM | TSM Price Prediction) presents one of the cleanest large-cap setups heading into next Thursday’s earnings report, and the setup gives retirement-focused investors a rare combination of visible earnings momentum,…
Warren Buffett spent decades assembling Berkshire Hathaway’s equity book around a simple principle: Own high-quality businesses that produce predictable cash flow and share it with owners. Three of the longest-tenured holdings in that portfolio,…
GE Aerospace (NYSE:GE | GE Price Prediction) looks like one of the cleanest large-cap industrial setups going into its July 16 earnings call, and the case for owning it does not hinge on waiting…
The space economy is transitioning from science project to revenue-generating industry, and July has produced a sharp pullback across the sector leaders. All three names below have sold off sharply over the past month,…
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of UNH last…
President Trump's "20 to 1" boast landed on trading desks as an inflation catalyst on July 9, 2026. The market was pricing in an October rate hike. Instead, the Fed moved on September 16,…
Consumer sentiment just hit 44.8 in May 2026, down 5 points from April and firmly in recessionary territory. Yet the actual spending data tells a different story: Total personal consumption expenditures climbed to $22,059.8…
July is shaping up to be the pivotal month for cloud computing investors in 2026. All three of the companies below report late-July results with their cloud franchises accelerating, not decelerating, into the print.…
The math is simple. A $1 million portfolio generating $100,000 in annual income requires a blended yield of 10%. That is achievable today, but only by leaning hard into the aggressive end of the…
The GLP-1 trade has matured from a single-stock story into a tiered opportunity set. Demand for obesity therapeutics keeps expanding as lower-cost, easier-to-administer oral pill versions of the current injectable GLP-1s are introduced to…
